Director defers cash retainer into Colgate (CL) stock units grant

Rhea-AI Filing Summary

Colgate-Palmolive director Lorrie M. Norrington acquired 293 shares of common stock at $89.45 per share as a grant under her compensation program. The footnote explains this represents a portion of her annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this award, she directly holds 42,769 shares of Colgate-Palmolive common stock, indicating this is a small, routine, compensation-related transaction rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider NORRINGTON LORRIE M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	293	$89.45	$26K

Holdings After Transaction: Common Stock — 42,769 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 293 shares Grant reference price: $89.45 per share Shares owned after grant: 42,769 shares

3 metrics

Shares granted 293 shares Non-derivative compensation grant to director on 2026-07-01

Grant reference price $89.45 per share Price per share used for the stock award

Shares owned after grant 42,769 shares Director’s direct Colgate-Palmolive holdings following the transaction

Key Terms

Deferred Compensation Plan for Non-Employee Directors, stock unit account, annual cash retainer

3 terms

Deferred Compensation Plan for Non-Employee Directors financial

"pursuant to the Deferred Compensation Plan for Non-Employee Directors."

stock unit account financial

"Portion of annual cash retainer deferred to a stock unit account"

annual cash retainer financial

"Portion of annual cash retainer deferred to a stock unit account"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:17 PM Accepted by SEC EDGAR 07/02/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NORRINGTON LORRIE M

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		293	A	$89.45	42,769	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Colgate-Palmolive (CL) director Lorrie M. Norrington report on this Form 4?

Director Lorrie M. Norrington reported receiving 293 Colgate-Palmolive common shares as a compensation grant. The award reflects part of her annual cash retainer, which she deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors.

Was the Colgate-Palmolive (CL) insider transaction a market purchase or a compensation grant?

The transaction was a compensation-related grant, not a market purchase. Norrington deferred a portion of her annual cash retainer into a stock unit account, receiving 293 shares at a reference price of $89.45 per share under the non-employee director deferred compensation plan.

How many Colgate-Palmolive (CL) shares does Lorrie M. Norrington hold after this Form 4 transaction?

After this compensation grant, Norrington directly holds 42,769 shares of Colgate-Palmolive common stock. The 293-share award is small relative to her total position, highlighting that this filing records routine board compensation rather than a large change in ownership.

What does the footnote to Lorrie M. Norrington’s Colgate-Palmolive (CL) Form 4 transaction explain?

The footnote states that the 293-share award represents a portion of Norrington’s annual cash retainer deferred to a stock unit account. This is done pursuant to Colgate-Palmolive’s Deferred Compensation Plan for Non-Employee Directors, clarifying the transaction is a standard director compensation mechanism.

Does Lorrie M. Norrington’s Colgate-Palmolive (CL) Form 4 indicate any derivative or option exercises?

No derivative or option exercises are shown in this Form 4. The filing lists only a non-derivative acquisition of 293 common shares as a grant or award. The derivative summary is empty, indicating no options or similar instruments were exercised in this report.